Arrowstreet Capital’s KORU Medical Systems KRMD Stock Holding History

Arrowstreet Capital’s Portfolio KRMD Stock Details KRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$222K	Buy	52,872 +34,472	+187%	+$141K	﹤0.01%	1845
2026 Q1	$79.5K	Buy	+18,400	New	+$91.2K	﹤0.01%	1804
2025 Q2	–	Sell	-50,404	Closed	-$128K	–	2012
2025 Q1	$128K	Buy	+50,404	New	+$187K	﹤0.01%	1756
2021 Q1	–	Sell	-100,918	Closed	-$608K	–	2384
2020 Q4	$608K	Sell	100,918 -61,349	-38%	-$343K	﹤0.01%	1966
2020 Q3	$1.17M	Buy	162,267 +38,400	+31%	+$341K	﹤0.01%	1770
2020 Q2	$1.11M	Buy	123,867 +30,778	+33%	+$311K	﹤0.01%	1728
2020 Q1	$698K	Buy	93,089 +60,809	+188%	+$409K	﹤0.01%	1433
2019 Q4	$211K	Buy	+32,280	New	+$157K	﹤0.01%	1616

Other funds holding KRMD

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

TCM

Topline Capital Management Santa Monica, California $386M AUM 2.37% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Simcoe Capital Spokane, Washington $164M AUM

MIM

Meros Investment Management Dallas, Texas $315M AUM 58.44% 1-Year Est. Return

LCM

Lionhunter Capital Management New York $222M AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ACM

Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return

Arrowstreet Capital's KRMD Position: Q2 2026 in Review

Arrowstreet Capital increased its KORU Medical Systems (KRMD) stake by 187% in Q2 2026, buying an estimated $141K and bringing the position to 52,872 shares worth $222K. The position accounts for ﹤0.01% of the portfolio, ranked #1845.

Arrowstreet Capital first reported a position in KRMD in Q4 2019 and has held it in 8 quarters since. The position peaked at $1.17M in Q3 2020. 85 funds tracked by Wall St. Rank hold KRMD as of Q2 2026.

Arrowstreet Capital held 52,872 shares of KORU Medical Systems worth $222K as of Q2 2026.
Arrowstreet Capital bought 34,472 KORU Medical Systems shares in Q2 2026, an estimated $141K.
KORU Medical Systems made up ﹤0.01% of Arrowstreet Capital's portfolio in Q2 2026, its #1845 holding.
Arrowstreet Capital first reported a position in KORU Medical Systems in Q4 2019 and has held it in 8 quarters since.
Arrowstreet Capital's KORU Medical Systems position peaked at $1.17M in Q3 2020.
85 funds tracked by Wall St. Rank held KORU Medical Systems as of Q2 2026.

Based on Arrowstreet Capital's 13F filing for Q2 2026, filed 13 Aug 2026.